UP!

News

Chelsea Therapeutics International Ltd. (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2014-06-23 Downgrade Wedbush Outperform to Neutral $8.00
2014-05-20 Downgrade Roth Capital Buy to Neutral $8.00 to $6.75
2014-05-09 Downgrade Needham & Company LLC Buy to Hold
2014-05-09 Downgrade JMP Securities Outperform to Market Perform
2014-02-19 Reiterated Needham Buy $8 to $10
2014-02-19 Boost Price Target Deutsche Bank Hold $5.00 to $8.00
2014-02-19 Boost Price Target Needham & Company LLC Buy $8.00 to $10.00
2014-01-17 Boost Price Target Roth Capital $7.00
2014-01-15 Reiterated Needham Buy $4 to $8
2014-01-15 Boost Price Target Ladenburg Thalmann $7.00
2014-01-15 Boost Price Target Deutsche Bank Hold to Hold $4.00 to $5.00
2014-01-15 Boost Price Target Needham & Company LLC Buy $4.00 to $8.00
2014-01-10 Lower Price Target Ladenburg Thalmann Buy $4.00 to $3.00
2014-01-10 Reiterated Rating Wedbush Outperform
2013-12-19 Initiated Coverage JMP Securities Outperform $8.00
2013-10-10 Reiterated Rating Ladenburg Thalmann Buy $4.00
2013-10-10 Boost Price Target Wedbush Outperform $7.00 to $8.00
2013-09-05 Reiterated Ladenburg Thalmann Buy $3.50 to $4
2013-02-20 Upgrade Needham Hold to Buy
2013-02-20 Upgrade Ladenburg Thalmann Neutral to Buy
2012-03-29 Downgrade Needham Buy to Hold
2012-03-29 Downgrade Ladenburg Thalmann Buy to Neutral
2010-12-21 Reiterated Ladenburg Thalmann Buy $8 to $10.50
2010-12-20 Reiterated Wedbush Outperform $8 to $10
2010-10-01 Reiterated Wedbush Outperform $10 to $8
2010-09-20 Reiterated Ladenburg Thalmann Buy $6 to $9
2010-03-23 Initiated Needham Buy $7
2010-01-19 Reiterated Roth Capital Buy $5 to $6
2009-09-25 Downgrade Ladenburg Thalmann Buy to Neutral
1970-01-01
2014-06-23 Downgrade Wedbush Outperform to Neutral $8.00
2014-05-20 Downgrade Roth Capital Buy to Neutral $8.00 to $6.75
2014-05-09 Downgrade Needham & Company LLC Buy to Hold
2014-05-09 Downgrade JMP Securities Outperform to Market Perform
2014-02-19 Reiterated Needham Buy $8 to $10

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In CHTP 0 funds of 2183 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
AUSTIN JOSIAH T 8.15%  (6432673) CHTP / GDP / MEIP /
VENROCK HEALTHCARE CAPITAL PARTNERS LP 6.57%  (5189934) ABIO / CHTP /
Pedder Simon Chief Executive Officer 0.62%  (488180) CHTP / OXGN /
LAU JOHNSON YIU NAM 0.01%  (11000) ATNX / CHTP /

Comments